156 related articles for article (PubMed ID: 35871674)
1. Clonal B-cell proliferations developing in the background of primary cutaneous CD4
Ates Ozdemir D; Akdoğan N; Okay M; Uner A; Saglam A
J Cutan Pathol; 2022 Nov; 49(11):971-977. PubMed ID: 35871674
[TBL] [Abstract][Full Text] [Related]
2. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
4. Prominent Blasts in Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder. A Reconsideration of Diagnostic Criteria.
Bakr F; Wain EM; Wong S; Palmer R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e190-e196. PubMed ID: 33989212
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lymphoproliferative disorders: Back to the future.
Willemze R
J Cutan Pathol; 2024 Jun; 51(6):468-476. PubMed ID: 38499969
[TBL] [Abstract][Full Text] [Related]
6. Primary Cutaneous CD4
Maurelli M; Colato C; Gisondi P; Girolomoni G
J Cutan Med Surg; 2017; 21(6):502-506. PubMed ID: 28605998
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4
Oschlies I; Kock K; Wüseke T; Richter J; Koch K; Wehkamp U; Klapper W
Histopathology; 2023 Feb; 82(3):485-494. PubMed ID: 36341542
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
Leeolou MC; Young PA; Saleem A; Narala S; Bae GH
Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809093
[TBL] [Abstract][Full Text] [Related]
9. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoproliferative disorder: Report of a case and review of the literature.
Keeling BH; Gavino ACP; Admirand J; Soldano AC
J Cutan Pathol; 2017 Nov; 44(11):944-947. PubMed ID: 28749588
[TBL] [Abstract][Full Text] [Related]
11. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
[TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
Bakr F; Wain EM; Barlow R; Robson A
Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
[TBL] [Abstract][Full Text] [Related]
13. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
Cetinözman F; Jansen PM; Willemze R
Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous CD4
Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
[TBL] [Abstract][Full Text] [Related]
15. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
16. Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder Mimicking Jessner Lymphocytic Infiltrate and Tumid Lupus-A Report of Two Cases.
Yi LG; Gru AA
Am J Dermatopathol; 2021 Dec; 43(12):e293-e297. PubMed ID: 34001748
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation.
Kim EJ; Aria AB; Wilmas K; Lewis DJ; Torres-Cabala CA; Nunez C; Dabaja BS; Duvic M
Pediatr Dermatol; 2019 Jan; 36(1):e23-e26. PubMed ID: 30548331
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
[TBL] [Abstract][Full Text] [Related]
19. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders.
Magro CM; Ruan J; Grossman M; Hedayat AA
Ann Diagn Pathol; 2019 Jun; 40():94-104. PubMed ID: 31077877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
